Showing results (251-260 of 481) with videos related to

Sort By:
Pageof 49
Cancers|January 8, 2025
The Proteomics of T-Cell and Early T-Cell Precursor (ETP) Acute Lymphocytic Leukemia: Prognostic Patterns in Adult and Pediatric-ETP ALLFieke W Hoff, Lourdes Sriraja, Yihua Qiu, et al.
The Journal of Cardiovascular Surgery|March 28, 2022
Warm humidified CO2 insufflation improves pericardial integrity for cardiac surgery: a randomized control studyReny Segal, Paul M Mezzavia, Roni B Krieser, et al.
Blood|February 21, 2014
PI3K p110δ uniquely promotes gain-of-function Shp2-induced GM-CSF hypersensitivity in a model of JMMLCharles B Goodwin, Xing Jun Li, Raghuveer S Mali, et al.
Scientific Reports|February 23, 2012
Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitisTej K Pareek, Abdelmadjid Belkadi, Sashi Kesavapany, et al.
Pediatric Blood & Cancer|November 2, 2017
Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology GroupRachel E Rau, ZoAnn Dreyer, Mi Rim Choi, et al.
Science (New York, N.Y.)|October 16, 1999
Molecular classification of cancer: class discovery and class prediction by gene expression monitoringT R Golub, D K Slonim, P Tamayo, et al.
Pediatric Blood & Cancer|July 27, 2010
Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium studyMatthew F Gorman, Lingyun Ji, Richard H Ko, et al.
The Journal of Clinical Endocrinology and Metabolism|August 18, 2000
Effects of testosterone replacement in hypogonadal menP J Snyder, H Peachey, J A Berlin, et al.
Cancer Science|April 12, 2019
Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemiaNitesh D Sharma, Christian K Nickl, Huining Kang, et al.
Elife|July 24, 2013
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancyStefan Heinrichs, Lillian F Conover, Carlos E Bueso-Ramos, et al.
Pageof 49